Preclinical models have demonstrated the ability of DS-8201 to modulate the tumor microenvironment (TME) towards an inflammatory phenotype, resulting in increased infiltration of dendritic cells (DCs) and CT8+T cells, as well as enhanced expression of PD-L1 and MHC-I molecules on tumor cells (29). The gene discussed is CD274; the disease is neoplasm.